We work with a variety of trusted partners to whom we deliver relevant information and compelling content. Our partners range from physicians and other health care professionals to pharmaceutical and biotech companies and more. Here’s what they have to say about us:
"We got a lot of media attention [for our trial] early on, which was great. We made sure to always have our website address or an email address mentioned in all the media, and [Contagion®] certainly helped with that early on. We got a lot of attention from that; a lot of participants have emailed us saying they'd seen the Contagion® webinar, or they'd read about us on CNN or Dr. Oz. It was a unique way to run a study, but it was very cool."
Matthew F. Pullen, MD, Infectious Diseases and International Medicine
"Thank you so very much for your publication, it's so informative. A past issue had the best explanation I have ever seen on CRISPR technology."
T.A. Sampson, Retired EMT/Cancer Survivor – Cane Hill, Arkansas
"It is really important that groups like OncLive® get out there and transmit [information] to other physicians and patients and everybody that is your readership. Your role is very important as communicators to the world."
Patrick Hwu, MD, of Moffitt Cancer Center
"At some of these meetings, some of the ‘sexy’ cancers get attention because famous people had it so people talk about it. Thyroid cancer is often overlooked for this reason, but so many people have thyroid nodules — half of Americans have thyroid nodules. This is super important, and I want to thank you for bringing attention to it. I believe strongly that the more we get the word out and educate people, the better."
Julie Ann Sosa, MD, MA, FACS, of University of California, San Francisco
"MD Anderson receives a lot of publications, but we usually defer to yours. I also really enjoy your videos that get posted on social media. It's a quick way to get information that has read out during conferences."
Jennifer Litton, MD, of The University of Texas MD Anderson Cancer
"OncLive® is a brand that is immediately recognized by doctors. There are some small institutions we work with, but they don’t have the name recognition OncLive® does."
Joseph Kim, of University of Kentucky Markey Cancer Center
"The Consortium of Multiple Sclerosis Centers (CMSC) is proud of our partnership and collaborative activities with NeurologyLive®/MJH Life Sciences®. Our joint programs have allowed us to reach health care professionals who formerly had limited access to education and information about MS and its ramifications. The team at NeurologyLive®/MJH Life Sciences® has allowed the CMSC to 'spread its wings' virtually, and create unique programs both accredited and nonaccredited for the multiple sclerosis team. Our goal, to hear the patient voice and meet the patient’s needs, has been more than fulfilled through our partnership."
Michael Birrer, MD
The rapidly changing health care industry requires us to stay ahead of the curve to create new ways of improving the quality of patient care through health care communications. Through an omnichannel approach, MJH Life Sciences® offers our partners countless opportunities to connect with their target audience across eight markets – oncology, primary care, specialty care, managed care, pharmacy, industry sciences, animal health, and dental. Leveraging our diverse portfolio of Strategic Alliance Partners, MJH delivers cutting-edge initiatives, content, research, and thought leadership throughout the industry.
The work we do at MJH Life Sciences® makes a difference. Whether empowering patients with cancer to conquer Kilimanjaro or honoring nurses who have changed the lives of their patients, our work improves both health care and the world around us. With more than 20 business divisions and 60+ brands, we have more than doubled in size over the last three years. We're always in pursuit of new acquisitions and developing markets, in turn expanding the opportunities offered to our partners.
